Enhe Bai

机构：Central South University, South University · ORCID：0000-0003-2581-0387

发表论文 16 篇 · 总被引 388 次 · h-index 11

代表论文

• Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma (2022 · Signal Transduction and Targeted Therapy · 被引 53)
• Co-delivery nanoparticles of doxorubicin and chloroquine for improving the anti-cancer effect in vitro (2018 · Nanotechnology · 被引 49)
• pH-Responsive Hydrogel as a Potential Oral Delivery System of Baicalin for Prolonging Gastroprotective Activity (2023 · Pharmaceutics · 被引 39)
• Design, synthesis, SAR discussion, in vitro and in vivo evaluation of novel selective EGFR modulator to inhibit L858R/T790M double mutants (2017 · European Journal of Medicinal Chemistry · 被引 38)
• Characterization of Chalkophomycin, a Copper(II) Metallophore with an Unprecedented Molecular Architecture (2021 · Journal of the American Chemical Society · 被引 37)
• Platensimycin-Encapsulated Poly(lactic- co -glycolic acid) and Poly(amidoamine) Dendrimers Nanoparticles with Enhanced Anti-Staphylococcal Activity in Vivo (2020 · Bioconjugate Chemistry · 被引 34)